Cargando…

Parkinson-related parkin reduces α-Synuclein phosphorylation in a gene transfer model

BACKGROUND: α-Synuclein aggregates in Lewy bodies and plays a central role in the pathogenesis of a group of neurodegenerative disorders, known as "Synucleinopathies", including Parkinson's disease. Parkin mutations result in loss of parkin E3-ubiquitin ligase activity and cause autos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khandelwal, Preeti J, Dumanis, Sonya B, Feng, Li Rebekah, Maguire-Zeiss, Kathleen, Rebeck, GW, Lashuel, Hilal A, Moussa, Charbel EH
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987994/ https://www.ncbi.nlm.nih.gov/pubmed/21050448 http://dx.doi.org/10.1186/1750-1326-5-47

Ejemplares similares

The Relationship between Parkin and Protein Aggregation in Neurodegenerative Diseases
por: Khandelwal, Preeti J., et al.
Publicado: (2010)

Ubiquitination Increases Parkin Activity to Promote Autophagic α-Synuclein Clearance
por: Lonskaya, Irina, et al.
Publicado: (2013)

Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies
por: Magalhães, Pedro, et al.
Publicado: (2022)

Nigral overexpression of alpha-synuclein in the absence of parkin enhances alpha-synuclein phosphorylation but does not modulate dopaminergic neurodegeneration
por: Van Rompuy, Anne-Sophie, et al.
Publicado: (2015)

Parkin depletion delays motor decline dose-dependently without overtly affecting neuropathology in α-synuclein transgenic mice
por: Fournier, Margot, et al.
Publicado: (2013)

Interaction between Parkin and α-Synuclein in PARK2-Mediated Parkinson’s Disease
por: Madsen, Daniel Aghaie, et al.
Publicado: (2021)

MMP13 Expression Is Increased Following Mutant α-Synuclein Exposure and Promotes Inflammatory Responses in Microglia
por: Sánchez, Kathryn, et al.
Publicado: (2020)

4395 alpha-Synuclein Induced Reactive Gliosis
por: Carey, Sean David, et al.
Publicado: (2020)

Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein
por: Béraud, Dawn, et al.
Publicado: (2012)

Extracellular Alpha-Synuclein Oligomers Induce Parkin S-Nitrosylation: Relevance to Sporadic Parkinson’s Disease Etiopathology
por: Wilkaniec, Anna, et al.
Publicado: (2018)

Photobiomodulation Suppresses Alpha-Synuclein-Induced Toxicity in an AAV-Based Rat Genetic Model of Parkinson’s Disease
por: Oueslati, Abid, et al.
Publicado: (2015)

PINK1 and Parkin – mitochondrial interplay between phosphorylation and ubiquitylation in Parkinson's disease
por: Kazlauskaite, Agne, et al.
Publicado: (2015)

Phosphorylation of Parkin at serine 131 by p38 MAPK promotes mitochondrial dysfunction and neuronal death in mutant A53T α-synuclein model of Parkinson’s disease
por: Chen, Jialong, et al.
Publicado: (2018)

PINK1-Mediated Phosphorylation of Parkin Boosts Parkin Activity in Drosophila
por: Shiba-Fukushima, Kahori, et al.
Publicado: (2014)

Protein kinase R dependent phosphorylation of α-synuclein regulates its membrane binding and aggregation
por: Reimer, Lasse, et al.
Publicado: (2022)

Exogenous Alpha-Synuclein Evoked Parkin Downregulation Promotes Mitochondrial Dysfunction in Neuronal Cells. Implications for Parkinson’s Disease Pathology
por: Wilkaniec, Anna, et al.
Publicado: (2021)

A simple, versatile and robust centrifugation‐based filtration protocol for the isolation and quantification of α‐synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in α‐synuclein research
por: Kumar, Senthil T., et al.
Publicado: (2020)

Phosphorylated ubiquitin chain is the genuine Parkin receptor
por: Okatsu, Kei, et al.
Publicado: (2015)

α-Synuclein Alters Toll-Like Receptor Expression
por: Béraud, Dawn, et al.
Publicado: (2011)

Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
por: Majbour, Nour K., et al.
Publicado: (2016)

Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
por: Stewart, Tessandra, et al.
Publicado: (2015)

Phosphorylated α-Synuclein-Copper Complex Formation in the Pathogenesis of Parkinson's Disease
por: Castillo-Gonzalez, Juan Antonio, et al.
Publicado: (2017)

Pronounced α-Synuclein Pathology in a Seeding-Based Mouse Model Is Not Sufficient to Induce Mitochondrial Respiration Deficits in the Striatum and Amygdala
por: Burtscher, Johannes, et al.
Publicado: (2020)

Pathological Relevance of Post-Translationally Modified Alpha-Synuclein (pSer87, pSer129, nTyr39) in Idiopathic Parkinson’s Disease and Multiple System Atrophy
por: Sonustun, Berkiye, et al.
Publicado: (2022)

Effect of Parkin on methamphetamine‐induced α‐synuclein degradation dysfunction in vitro and in vivo
por: Meng, Yunle, et al.
Publicado: (2020)

Empagliflozin attenuates neurodegeneration through antioxidant, anti-inflammatory, and modulation of α-synuclein and Parkin levels in rotenone-induced Parkinson’s disease in rats
por: Ahmed, Sanaa, et al.
Publicado: (2022)

Impact of altered phosphorylation on loss of function of juvenile Parkinsonism–associated genetic variants of the E3 ligase parkin
por: Aguirre, Jacob D., et al.
Publicado: (2018)

Parkin beyond Parkinson’s Disease—A Functional Meaning of Parkin Downregulation in TDP-43 Proteinopathies
por: Gaweda-Walerych, Katarzyna, et al.
Publicado: (2021)

The Roles of PINK1 and Parkin in Parkinson's Disease
por: Jones, Rachel
Publicado: (2010)

Is PARKIN parkinsonism a cancer predisposition syndrome?
por: Schüle, Birgitt, et al.
Publicado: (2015)

Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease
por: Oliveira, Luis M. A., et al.
Publicado: (2021)

PINK1-mediated phosphorylation of the Parkin ubiquitin-like domain primes mitochondrial translocation of Parkin and regulates mitophagy
por: Shiba-Fukushima, Kahori, et al.
Publicado: (2012)

Differential Aggregation and Phosphorylation of Alpha Synuclein in Membrane Compartments Associated With Parkinson Disease
por: Canerina-Amaro, Ana, et al.
Publicado: (2019)

Optimization of the Detection Method for Phosphorylated α-Synuclein in Parkinson Disease by Skin Biopsy
por: Liu, Xiaojing, et al.
Publicado: (2020)

Alterations of Erythrocytic Phosphorylated Alpha-Synuclein in Different Subtypes and Stages of Parkinson's Disease
por: Li, Xu-Ying, et al.
Publicado: (2021)

Phosphorylated α-synuclein in diluted human serum as a biomarker for Parkinson's disease
por: Chen, Wei-Ru, et al.
Publicado: (2022)

Identification and nanomechanical characterization of the fundamental single-strand protofilaments of amyloid α-synuclein fibrils
por: Ruggeri, Francesco Simone, et al.
Publicado: (2018)

Phosphorylation of Parkin at serine 65 is essential for its activation in vivo
por: McWilliams, Thomas G., et al.
Publicado: (2018)

Tyrosine kinase inhibition increases functional parkin-Beclin-1 interaction and enhances amyloid clearance and cognitive performance
por: Lonskaya, Irina, et al.
Publicado: (2013)

Mitophagy and Parkinson's disease: The PINK1–parkin link()
por: Deas, Emma, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_gehpp3dtnijj5g0u7h0tlu116l